Evidence Lacking For Bosom Max Claims; ERSP Advises Discontinuation
This article was originally published in The Rose Sheet
Executive Summary
Claims for breast enhancement system Bosom Max are not properly substantiated, according to the Electronic Retailing Self-Regulation Program, which is reporting the advertiser to regulatory authorities.